Passage Bio, Inc. (PASG) Tops Q3 EPS by 29c
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Join SI Premium – FREE
Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.29 better than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
- Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
